Log in to search using one of your social media accounts:

 

Amyotrophic Lateral Sclerosis after Receiving the Human Papilloma Virus Vaccine: A Case Report of a 15-year-old Girl.

Amyotrophic Lateral Sclerosis after Receiving the Human Papilloma Virus Vaccine: A Case Report of a 15-year-old Girl. Intern Med. 2018 Feb 09;: Authors: Hikiami R, Yamakado H, Tatsumi S, Ayaki T, Hashi Y, Yamashita H, Sawamoto N, Tsuji T, Urushitani M, Takahashi R Abstract We herein report a 15-year-old girl who developed rapid progressive muscle weakness soon after the third injection of a bivalent human papilloma virus (HPV) vaccine. Although immunotherapies were performed for possible vaccine-related disorders, she died of respiratory failure 14 months after the onset of the disease. A genetic analysis identified a heterozygous p.P525L mutation of the fused in sarcoma (FUS) gene, and a histopathological analysis was also consistent with FUS-associated amyotrophic lateral sclerosis (ALS) without any evidence of neuroinflammation. We concluded the diagnosis to be FUS-ALS, although we cannot completely rule out the possibility that the vaccination worked as a trigger. PMID: 29434138 [PubMed - as supplied by publisher]
Source: Internal Medicine - Category: Internal Medicine Tags: Intern Med Source Type: research

Related Links:

Abstract BACKGROUND: The controlled temperature chain (CTC) strategy allows vaccines to be kept outside the cold chain for a short period of time. In remote rural areas, the CTC strategy for the hepatitis B virus (HBV) birth dose vaccination could improve its geographical coverage and timeliness of delivery, but with additional outreach costs. We assessed the cost-effectiveness of the CTC strategy for the HBV birth dose across six world regions and 72 countries according to their HBV prevalence, delivery costs, and birth dose coverage and timing. METHODS: By use of a mathematical model of perinatal HBV transm...
Source: Rural Remote Health - Category: Rural Health Authors: Tags: Lancet Glob Health Source Type: research
The country has come tantalizingly close to eradicating the virus in recent years, only to be foiled by instability, mistrust and attacks on vaccinators.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Poliomyelitis Vaccination and Immunization Baluchistan (Pakistan) Viruses Source Type: news
GOMA, Democratic Republic of Congo (Reuters) - Health workers in Democratic Republic of Congo will begin a vaccination campaign on Monday aimed at containing an outbreak of the deadly Ebola virus, a spokeswoman for the health ministry said.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Vincent, Kathy, and Alan review the ongoing outbreak of Ebola virus in the Democratic Republic of the Congo, and the finding that mutations identified in the 2015 West African epidemic do not alter pathogenesis in animals. <span data-mce-type=”bookmark” style=”display: inline-block; width: 0px; overflow: hidden; line-height: […]
Source: virology blog - Category: Virology Authors: Tags: This Week in Virology Democratic Republic of the Congo ebolavirus Makona Mayingo pathogenesis transmission vaccine viral virology Ebola virus virulence viruses Source Type: blogs
GOMA, Democratic Republic of Congo (Reuters) - Health workers in Democratic Republic of Congo will begin a vaccination campaign on Monday aimed at containing an outbreak of the deadly Ebola virus, a spokeswoman for the health ministry said on Sunday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Congo will begin administering an experimental Ebola vaccine Monday in Mbandaka, the northwestern city of 1.2 million where the deadly disease has infected some residents, Congo's health minister announced
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
ABIDJAN (Reuters) - Health workers in Democratic Republic of Congo will begin a vaccination campaign on Monday aimed at containing an outbreak of the deadly Ebola virus, a spokeswoman for the health ministry said on Sunday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Authors: Sharma P, King GT, Shinde SS, Purev E, Jimeno A Abstract B-cell non-Hodgkin's lymphomas are the most common hematological malignancies, which despite improvements in chemo-immunotherapy, carry a uniformly poor prognosis in the relapsed/refractory setting. CD19 is an antigen expressed on the surface of most malignancies arising from the B cells, and adoptive transfer of anti-CD19 chimeric antigen receptor (CAR)-expressing T cells has been shown to be effective in treating these B-cell malignancies. Axicabtagene ciloleucel (axi-cel, KTE-C19) is an autologous anti-CD19 CAR T-cell therapy which has shown high ...
Source: Drugs of Today - Category: Drugs & Pharmacology Tags: Drugs Today (Barc) Source Type: research
(Natural News) Vaccines are one of the most hotly debated topics today, and their defenders often ask those who voice concerns about vaccines to furnish evidence that they’re bad. While there is no shortage of studies showing the harm they cause, a recent incident reminds us that there is likely a lot more information out...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
Publication date: Available online 19 May 2018 Source:Seminars in Cancer Biology Author(s): George Cyriac, Leena Gandhi Immune checkpoint inhibition with anti-PD-1 therapy has been notably successful in non-small cell lung cancer (NSCLC) and changed standard practice in multiple settings. However, despite some durable benefits seen, the majority of unselected patients with NSCLC fail to respond to checkpoint inhibitors. Patient selection is crucial and will become even more important in the development of combination therapies with immune checkpoint inhibitors. PD-L1 expression by immunohistochemistry (IHC) has emerged as...
Source: Seminars in Cancer Biology - Category: Cancer & Oncology Source Type: research
More News: ALS | Brain | Cervical Cancer Vaccine | Genetics | Girls | Human Papillomavirus (HPV) | Immunotherapy | Internal Medicine | Neurology | Respiratory Medicine | Sarcomas | Vaccines